Patents Assigned to YANGZHOU LIANAO BIOMEDICAL CO., LTD.
  • Patent number: 11952341
    Abstract: The invention discloses a method of preparing a high chiral purity lactam intermediate D comprising a step of reducing a compound C to lactam intermediate D in a solvent by hydrogenation reduction using a heavy metal catalyst and a chiral inducer. Brivaracetam can be prepared in a single step using the lactam intermediate D. The synthesis route is short, reaction conditions are mild, post-treatment is simple, reaction yield is high, chiral selectivity is good, and production cost is low. The conversion rate of the compound C in the reaction is 81%, and the DE value of the compound D is more than 99.0%, which is suitable for industrial production.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: April 9, 2024
    Assignees: YANGZHOU AORUITE PHARMACEUTICAL CO., LTD., YANGZHOU LIANAO BIOMEDICAL CO., LTD.
    Inventors: Zhenpeng Yu, Fei Xiao, Guoping Wang, Shuxian Qi, He Gao